Bone Calcium Regulation
Bone Calcium Regulation Therapeutic Line
Past the age of 35, we all begin to lose bone calcium, it’s a natural process that is called Osteoporosis, when the bones lose around 30% of their mass. In Mexico there are over 5 million women diagnosed with Osteoporosis who face an elevated risk of hip and bone fractures that could cause death.
Fosfonat® | Ibandronic Acid
Treatment of post-menopausal osteoporosis, to reduce the risk of fractures.
Osteoporosis prevention: it can be important to consider the presence of the following risk factors with the use of Ibandronate to prevent osteoporosis, since they are associated to an increase in the risk to develop osteoporosis and fractures: in post-menopausal women over the age of 60 the loss of bone bass is especially fast, family history of osteoporosis, premature menopause, previous fractures, accelerated bone replacement, low bone mineral density (at least 1.0 T-score under the premenopausal average), ectomorphs, Caucasian and Asian folks, and smokers.
Presentations
Box with one 150 mg tablet
Zolnic® | Zoledronic Acid
Bone metabolism regulator; prevention of loss of bone mass induced by hormonal treatment in patients with prostate or breast cancer; prevention of bone complications (pathological fractures, medullar compression, irritation or bone surgery or tumor induced hypercalcemia) in patients with advanced malignant neoplasm that affect the bone directly; treatment of malignant neoplasms hypercalcemia (MNH)
Presentations
- Box with one bottle of 4mg/5ml injectable solution
Zondra® | Sodium Alendronate
Indicated as an assistant in the treatment of post-menopausal osteoporosis to prevent fractures, including hip and spinal fractures (spinal compression fractures).
Presentations
Box with thirty 10 mg tablets
